The Cigna Group (NYSE:CI) Price Target Lowered to $390.00 at Truist Financial

The Cigna Group (NYSE:CI) had its price target reduced by Truist Financial from $420.00 to $390.00 in a report issued on Monday,Benzinga reports. The brokerage currently has a “buy” rating on the health services provider’s stock. Truist Financial’s price target points to a potential upside of 38.94% from the company’s previous close.

Several other equities analysts also recently commented on CI. Royal Bank of Canada lowered their price objective on shares of The Cigna Group from $384.00 to $377.00 and set an “outperform” rating for the company in a research note on Friday, November 1st. Deutsche Bank Aktiengesellschaft cut their price objective on The Cigna Group from $398.00 to $394.00 and set a “buy” rating on the stock in a research report on Monday, November 4th. Piper Sandler reaffirmed an “overweight” rating and issued a $394.00 price target (up previously from $392.00) on shares of The Cigna Group in a research note on Tuesday, November 5th. StockNews.com downgraded shares of The Cigna Group from a “strong-buy” rating to a “buy” rating in a research report on Monday, November 4th. Finally, Barclays raised their target price on shares of The Cigna Group from $405.00 to $420.00 and gave the stock an “overweight” rating in a research report on Tuesday, November 5th. One research analyst has rated the stock with a hold rating, fourteen have assigned a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Buy” and a consensus price target of $395.93.

The Cigna Group Trading Up 2.3 %

NYSE CI opened at $280.70 on Monday. The firm has a market cap of $78.08 billion, a PE ratio of 26.48, a price-to-earnings-growth ratio of 0.88 and a beta of 0.54. The Cigna Group has a 1-year low of $262.03 and a 1-year high of $370.83. The stock has a 50-day moving average of $308.20 and a 200-day moving average of $330.51. The company has a current ratio of 0.72, a quick ratio of 0.72 and a debt-to-equity ratio of 0.71.

The Cigna Group (NYSE:CI) last announced its quarterly earnings data on Thursday, October 31st. The health services provider reported $7.51 earnings per share for the quarter, beating the consensus estimate of $7.22 by $0.29. The Cigna Group had a return on equity of 18.42% and a net margin of 1.31%. The firm had revenue of $63.70 billion during the quarter, compared to the consensus estimate of $59.58 billion. During the same quarter in the previous year, the company posted $6.77 earnings per share. The business’s revenue was up 29.8% on a year-over-year basis. As a group, sell-side analysts forecast that The Cigna Group will post 28.5 EPS for the current year.

Institutional Investors Weigh In On The Cigna Group

Several large investors have recently bought and sold shares of the business. Ulland Investment Advisors LLC raised its holdings in The Cigna Group by 2,500.0% in the 3rd quarter. Ulland Investment Advisors LLC now owns 104 shares of the health services provider’s stock worth $36,000 after purchasing an additional 100 shares during the period. Prospera Private Wealth LLC purchased a new position in shares of The Cigna Group during the 3rd quarter valued at about $37,000. Harbor Capital Advisors Inc. bought a new position in shares of The Cigna Group during the 3rd quarter valued at approximately $45,000. Intact Investment Management Inc. bought a new stake in The Cigna Group during the 3rd quarter worth approximately $69,000. Finally, Stone House Investment Management LLC lifted its holdings in The Cigna Group by 25.0% during the third quarter. Stone House Investment Management LLC now owns 200 shares of the health services provider’s stock valued at $69,000 after purchasing an additional 40 shares in the last quarter. 86.99% of the stock is currently owned by institutional investors.

The Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.